UK pharma association announces new commercial and communications director
This article was originally published in Scrip
Executive Summary
The Association of the British Pharmaceutical Industry (ABPI) has appointed Alison Clough commercial and communications director. The role is newly created following the departures of David Lewis, director of corporate affairs, and David Fisher, the association's corporate director, in December. Ms Clough will assume responsibility for the ABPI's commercial and communications functions and will co-ordinate its four work streams, which are based on value, innovation, trust and access (VITA). Ms Clough joined the ABPI in May from a management position at Innovex.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.